{
    "clinical_study": {
        "@rank": "23344", 
        "arm_group": {
            "arm_group_label": "Fitted with Reza Band UES Assist Device"
        }, 
        "brief_summary": {
            "textblock": "The purpose of the study is to determine the safety and effectiveness of non-invasive Reza\n      Band UES Assist Device for the treatment of esophagopharyngeal reflux with extra-esophageal\n      symptoms (chronic cough, choking, aspiration, chronic post nasal drip, globus, sore throat,\n      throat clearing)."
        }, 
        "brief_title": "Treatment of Extraesophageal Reflux With the Reza Band UES Assist Device", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Extraesophageal Reflux Disease", 
        "condition_browse": {
            "mesh_term": "Gastroesophageal Reflux"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 year of age or older\n\n          -  The patient must be willing and able to provide informed consent.\n\n          -  Understands the clinical study requirements and is able to comply with follow-up\n             schedule.\n\n          -  Clinically diagnosed with esophagopharyngeal reflux with extra-esophageal symptoms\n             (i.e., chronic cough, choking, aspiration, chronic post nasal drip, globus, sore\n             throat, throat clearing)\n\n          -  Reflux Symptom Index (RSI) >13\n\n        Exclusion Criteria:\n\n          -  Currently being treated with another investigational medical device and/or drug\n\n          -  Currently receiving treatment for sleep apnea with continuous positive airway\n             pressure (CPAP)\n\n          -  The patient is female and is of child bearing potential and is not using an\n             acceptable method of birth control, or is pregnant or breast feeding.\n\n          -  Previous head or neck surgery or radiation\n\n          -  Carotid artery disease, thyroid disease, or history of cerebral vascular disease\n\n          -  Suspected esophageal cancer\n\n          -  Has either a pacemaker or implanted cardioverter defibrillator (ICD)\n\n          -  Nasopharyngeal cancer\n\n          -  Previously undergone Nissen Fundoplication"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients that have been clinically diagnosed with esophagopharyngeal reflux with\n        extra-esophageal symptoms (i.e., chronic cough, choking, aspiration, chronic post nasal\n        drip, globus, sore throat, throat clearing)"
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01857713", 
            "org_study_id": "RB-001-02"
        }, 
        "intervention": {
            "arm_group_label": "Fitted with Reza Band UES Assist Device", 
            "intervention_name": "Reza Band UES Assist Device", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 5, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10016"
                    }, 
                    "name": "Madison ENT & Facial Plastic surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10016"
                    }, 
                    "name": "Dr. Alan Raymond"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37212"
                    }, 
                    "name": "Vanderbilt University"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Multi-Center, Non-Randomized, Prospective Study of the Reza Band\u2122 Upper Esophageal Sphincter (UES) Assist Device for the Treatment of Esophagopharyngeal Reflux", 
        "other_outcome": [
            {
                "description": "Patients provide their perception of the device at the end of the study.", 
                "measure": "Patient Satisfaction", 
                "safety_issue": "No", 
                "time_frame": "4 Weeks"
            }, 
            {
                "description": "Investigators provide their perception of the device at the end of the study.", 
                "measure": "Investigator Questionnaire", 
                "safety_issue": "No", 
                "time_frame": "4 Weeks"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "The RSI is a validated nine-item patient-administered outcome questionnaire designed to document symptoms and severity. Patients are asked to rate how nine problems have affected them on a scale of 0 (no problem) to 5 (severe problem), with a maximum total score of 45). For the purposes of this study Question 9 (relating to heartburn, etc.) will not be included in the total score for RSI. Therefore, for this study, the maximum total score will be 40. However, the data for Question 9 will be collected.", 
                "measure": "Reflux Symptom Index (RSI)", 
                "safety_issue": "No", 
                "time_frame": "4 Weeks"
            }, 
            {
                "description": "All adverse reactions being reported will be evaluated with the frequency and percent of subjects of each reaction being summarized by severity and by relationship to the Reza Band UES Assist Device.", 
                "measure": "Primary Safety", 
                "safety_issue": "Yes", 
                "time_frame": "4 Weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01857713"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "The SF-36 is a multidimensional health-related Quality of Life questionnaire, which measures 8 health related parameters (physical function, social function, physical role, emotional role, mental health, energy, pain, general health perceptions). Each parameter is scored from 0 to 100. The SF-36 also includes a list of 18 self-reported chronic conditions.", 
                "measure": "Short Form (36) Health Survey (SF-36)", 
                "safety_issue": "No", 
                "time_frame": "4 Weeks"
            }, 
            {
                "description": "The FOSQ is a self-report measure designed to assess the impact of disorders of excessive sleepiness (DOES) on multiple activities of everyday living that includes areas of physical, mental and social functioning.", 
                "measure": "Functional Outcomes of Sleep Questionnaire (FOSQ)", 
                "safety_issue": "No", 
                "time_frame": "4 Weeks"
            }
        ], 
        "source": "Somna Therapeutics, L.L.C.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Somna Therapeutics, L.L.C.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "September 2013"
    }
}